In today's episode, the first in our ongoing “Live Chat” series — informal conversations with members of the medical community, advocates, and patients about what matters most to them and to us, hosts Victoria Goldberg and Dr. Ellen Landsberger are joined by Dr. Sherry Shen, a breast cancer medical oncologist at Memorial Sloan Kettering Cancer Center, for a clear, patient-centered conversation on the evolving role of SERDs (Selective Estrogen Receptor Degraders) in hormone receptor–positive m...
All content for Live from Stage 4: MBC News for Us, by Us is the property of Victoria Goldberg and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In today's episode, the first in our ongoing “Live Chat” series — informal conversations with members of the medical community, advocates, and patients about what matters most to them and to us, hosts Victoria Goldberg and Dr. Ellen Landsberger are joined by Dr. Sherry Shen, a breast cancer medical oncologist at Memorial Sloan Kettering Cancer Center, for a clear, patient-centered conversation on the evolving role of SERDs (Selective Estrogen Receptor Degraders) in hormone receptor–positive m...
In today's episode, the first in our ongoing “Live Chat” series — informal conversations with members of the medical community, advocates, and patients about what matters most to them and to us, hosts Victoria Goldberg and Dr. Ellen Landsberger are joined by Dr. Sherry Shen, a breast cancer medical oncologist at Memorial Sloan Kettering Cancer Center, for a clear, patient-centered conversation on the evolving role of SERDs (Selective Estrogen Receptor Degraders) in hormone receptor–positive m...
This is the first episode of the recurring MBC Insiders series created by and starring the podcast team. In the first episode, published on October 13th, the National Metastatic Breast Cancer Awareness Day, we meet seven panelists with 80+ years living with Metastatic Breast Cancer between them and they are here to share the hard-won wisdom of true MBC insiders. We'll explore the issues that matter most to people living with MBC, including how the language clinicians and media use...
In this episode of "Live from Stage 4: MBC News for Us, by Us," host Victoria Goldberg sits down with Dr. Gloria Echeverria, a leading researcher at Baylor College of Medicine, to discuss the urgent challenges facing cancer research in the United States. Dr. Echeverria shares her career path from PhD student to running her own lab, focusing on triple negative breast cancer (TNBC)—one of the most aggressive and difficult-to-treat forms of the disease. The conversation delves into the rea...
What if the decades of progress against cancer — the breakthroughs, the rising survival rates, the new vaccines and cutting‑edge therapies — were suddenly put in jeopardy? Five decades after the “war on cancer” began, the U.S. has built a world‑class research engine that has pushed survival from roughly 49% in the 1970s to about 68% today. But that hard‑won momentum now faces existential threats: canceled grants and clinical trials, proposals to slash the National Cancer Institute budget, and...
In this powerful panel episode, hosts Victoria Goldberg and Abigail Johnston are joined by Dr. Jill Tirabassi and Alexis Desai—each bringing their unique perspective as patients, advocates, and experts living with metastatic breast cancer (MBC). Together, they share personal stories about navigating diagnosis, the critical role of research in extending lives, and the real-world challenges of accessing clinical trials. The conversation dives deep into why research funding matters, how ad...
In today's episode, the first in our ongoing “Live Chat” series — informal conversations with members of the medical community, advocates, and patients about what matters most to them and to us, hosts Victoria Goldberg and Dr. Ellen Landsberger are joined by Dr. Sherry Shen, a breast cancer medical oncologist at Memorial Sloan Kettering Cancer Center, for a clear, patient-centered conversation on the evolving role of SERDs (Selective Estrogen Receptor Degraders) in hormone receptor–positive m...
